Company Filing History:
1 out of 845 
1 out of 109 
Years Active: 2012
Title: Allan Sheppard: Innovator in Stem Cell Differentiation
Introduction
Allan Sheppard is a notable inventor based in Cambridge, New Zealand. He has made significant contributions to the field of stem cell research, particularly in the differentiation of pluripotent human embryonic stem cells. His innovative approaches have the potential to advance medical science and therapeutic applications.
Latest Patents
Allan Sheppard holds a patent titled "Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors." This invention provides compositions and methods for producing differentiated mammalian cells. The methods involve culturing cells on a feeder layer or under feeder-free conditions while contacting the cells with an inhibitor of the PI3-kinase pathway and a member of the TGFb family. The differentiated cells can be selected from mesendodermal, mesodermal, and endodermal cell types. He has 1 patent to his name.
Career Highlights
Throughout his career, Allan has worked with esteemed organizations, including the University of Georgia Research Foundation, Inc. and Viacyte, Inc. His work has focused on advancing the understanding and application of stem cell technology, which is crucial for regenerative medicine.
Collaborations
Allan has collaborated with notable colleagues in his field, including Stephen Dalton and Karen Jones. These partnerships have contributed to the development of innovative techniques and methodologies in stem cell research.
Conclusion
Allan Sheppard's contributions to stem cell differentiation highlight his role as an innovator in the field. His patent and collaborations reflect his commitment to advancing medical science through innovative research.